190 related articles for article (PubMed ID: 30738628)
1. The clinical relevance of molecular diagnosis in children allergic to grass pollen and treated with allergen immunotherapy.
Barberi S; Traina G; Landi M; De Castro G; Peroni D; Licari A; Marseglia G; Ciprandi G
Allergol Immunopathol (Madr); 2019; 47(3):309-310. PubMed ID: 30738628
[No Abstract] [Full Text] [Related]
2. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen.
Martínez-Cañavate Burgos A; Torres-Borrego J; Molina Terán AB; Corzo JL; García BE; Rodríguez Pacheco R; Moreno Aguilar C; Dávila I
Pediatr Allergy Immunol; 2018 Jun; 29(4):369-374. PubMed ID: 29369414
[TBL] [Abstract][Full Text] [Related]
3. Ultra-short-course booster allergen immunotherapy.
Pfaar O; Pieper-Fürst U; Mösges R
Immunotherapy; 2018 Jun; 10(7):525-528. PubMed ID: 29562789
[No Abstract] [Full Text] [Related]
4. Which allergen extract for grass pollen immunotherapy? An in vitro study.
Marcucci F; Sensi L; Di Cara G; Incorvaia C; Puccinelli P; Scurati S; Frati F
Immunol Invest; 2010; 39(6):635-44. PubMed ID: 20653430
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
Didier A; Malling HJ; Worm M; Horak F; Jäger S; Montagut A; André C; de Beaumont O; Melac M
J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
[TBL] [Abstract][Full Text] [Related]
6. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
7. Detection of pan-allergens in commercial pollen extracts for allergen immunotherapy.
Asero R; Mistrello G; Amato S
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):180-5. PubMed ID: 27238577
[TBL] [Abstract][Full Text] [Related]
8. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten M; Malling HJ; Blom L; Poulsen BC; Poulsen LK
J Allergy Clin Immunol; 2013 Nov; 132(5):1248-1252.e5. PubMed ID: 24035151
[No Abstract] [Full Text] [Related]
9. Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?
Nelson HS; Durham SR
J Allergy Clin Immunol Pract; 2017; 5(1):52-57. PubMed ID: 28065341
[No Abstract] [Full Text] [Related]
10. Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.
Moingeon P; Cox L
Expert Rev Clin Immunol; 2016 Jun; 12(6):617-23. PubMed ID: 26813047
[TBL] [Abstract][Full Text] [Related]
11. Long-term immunological effects of Japanese cedar pollen-based subcutaneous immunotherapy.
Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y
Allergol Int; 2018 Jul; 67(3):408-410. PubMed ID: 29198713
[No Abstract] [Full Text] [Related]
12. IgE Reactivity to Polcalcins Varies According to Pollen Source.
Asero R; Mistrello G; Amato S
J Investig Allergol Clin Immunol; 2016; 26(6):362-365. PubMed ID: 27996942
[TBL] [Abstract][Full Text] [Related]
13. How molecular diagnosis may modify immunotherapy prescription in multi-sensitized pollen-allergic children.
Del-Río Camacho G; Montes Arjona AM; Fernández-Cantalejo Padial J; Rodríguez Catalán J
Allergol Immunopathol (Madr); 2018; 46(6):552-556. PubMed ID: 30017214
[TBL] [Abstract][Full Text] [Related]
14. Early improvement in basophil sensitivity predicts symptom relief with grass pollen immunotherapy.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2014 Sep; 134(3):741-744.e5. PubMed ID: 24934275
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.
Wahn U; Tabar A; Kuna P; Halken S; Montagut A; de Beaumont O; Le Gall M;
J Allergy Clin Immunol; 2009 Jan; 123(1):160-166.e3. PubMed ID: 19046761
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy.
Zielen S; Gabrielpillai J; Herrmann E; Schulze J; Schubert R; Rosewich M
Immunotherapy; 2018 Jun; 10(7):529-536. PubMed ID: 29562801
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of grass pollen-induced allergic rhinitis in specialized current clinical practice in Spain.
Valero A; Chivato T; Justicia JL; Navarro AM;
Allergy Asthma Proc; 2011; 32(5):384-9. PubMed ID: 22195692
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy: allergen specific or placebo effect?
Kette F; Smith W
J Allergy Clin Immunol; 2011 Aug; 128(2):430; author reply 430-2. PubMed ID: 21665261
[No Abstract] [Full Text] [Related]
19. Oligoclonal analysis of the atopic T cell response to the group 1 allergen of Cynodon dactylon (bermuda grass) pollen: pre- and post-allergen-specific immunotherapy.
Eusebius NP; Papalia L; Suphioglu C; McLellan SC; Varney M; Rolland JM; O'Hehir RE
Int Arch Allergy Immunol; 2002 Mar; 127(3):234-44. PubMed ID: 11979049
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
